Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial.

Wang CS, Travers C, McCracken C, Leong T, Gbadegesin R, Quiroga A, Benfield MR, Hidalgo G, Srivastava T, Lo M, Yadin O, Mathias R, Araya CE, Khalid M, Orjuela A, Zaritsky J, Al-Akash S, Kamel M, Greenbaum LA.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1859-1865. doi: 10.2215/CJN.06890618. Epub 2018 Nov 15.

PMID:
30442868
2.

Improved survival with recent Post-Transplant Lymphoproliferative Disorder (PTLD) in children with kidney transplants.

Dharnidharka VR, Martz KL, Stablein DM, Benfield MR.

Am J Transplant. 2011 Apr;11(4):751-8. doi: 10.1111/j.1600-6143.2011.03470.x.

3.

A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation.

Benfield MR, Bartosh S, Ikle D, Warshaw B, Bridges N, Morrison Y, Harmon W.

Am J Transplant. 2010 Jan;10(1):81-8. doi: 10.1111/j.1600-6143.2009.02767.x. Epub 2009 Jul 28.

4.

Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.

Zappitelli M, Goldstein SL, Symons JM, Somers MJ, Baum MA, Brophy PD, Blowey D, Fortenberry JD, Chua AN, Flores FX, Benfield MR, Alexander SR, Askenazi D, Hackbarth R, Bunchman TE; Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.

Crit Care Med. 2008 Dec;36(12):3239-45. doi: 10.1097/CCM.0b013e31818f3f40.

PMID:
18936697
5.

Pediatric transplantation in the United States, 1997-2006.

Magee JC, Krishnan SM, Benfield MR, Hsu DT, Shneider BL.

Am J Transplant. 2008 Apr;8(4 Pt 2):935-45. doi: 10.1111/j.1600-6143.2008.02172.x.

6.

The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry.

Hackbarth R, Bunchman TE, Chua AN, Somers MJ, Baum M, Symons JM, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Alexander SR, Mahan JD, McBryde KD, Benfield MR, Goldstein SL.

Int J Artif Organs. 2007 Dec;30(12):1116-21.

PMID:
18203074
7.

Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry.

Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL.

Clin J Am Soc Nephrol. 2007 Jul;2(4):732-8. Epub 2007 May 18.

8.

Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.

Schachter AD, Benfield MR, Wyatt RJ, Grimm PC, Fennell RS, Herrin JT, Lirenman DS, McDonald RA, Munoz-Arizpe R, Harmon WE.

Pediatr Transplant. 2006 Dec;10(8):914-9.

9.

Are the Banff 97 criteria for renal allograft biopsy specimen adequacy achievable in children?

Benfield MR.

Nat Clin Pract Nephrol. 2006 Sep;2(9):488-9. No abstract available.

PMID:
16941041
10.

A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation.

Benfield MR, Tejani A, Harmon WE, McDonald R, Stablein DM, McIntosh M, Rose S; CCTPT Study Group.

Pediatr Transplant. 2005 Jun;9(3):282-92.

PMID:
15910382
11.

Current status of kidney transplant: update 2003.

Benfield MR.

Pediatr Clin North Am. 2003 Dec;50(6):1301-34. Review.

PMID:
14710782
12.

Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.

Benfield MR, McDonald RA, Bartosh S, Ho PL, Harmon W.

Pediatr Transplant. 2003 Aug;7(4):321-35.

PMID:
12890012
13.

Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation.

Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR.

Pediatr Nephrol. 2002 Mar;17(3):150-4.

PMID:
11956849
14.

Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients.

Hutchings A, Guay-Woodford L, Thomas JM, Young CJ, Purcell WM, Pravica V, Perrey C, Hutchinson IV, Benfield MR.

Pediatr Transplant. 2002 Feb;6(1):69-77.

PMID:
11906646
15.

Increased costimulatory responses in African-American kidney allograft recipients.

Hutchings A, Purcell WM, Benfield MR.

Transplantation. 2001 Mar 15;71(5):692-5.

PMID:
11292304
16.

Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis.

Schachter AD, Strehlau J, Zurakowski D, Vasconcellos L, Kim YS, Zheng XX, Gunshin Y, Overstreet SL, Benfield MR, Tejani A, Harmon WE, Herrin JT, Strom TB.

Transplantation. 2000 Oct 15;70(7):1107-10.

PMID:
11045652
17.

Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.

Hutchings A, Purcell WM, Benfield MR.

Clin Exp Immunol. 1999 Nov;118(2):247-52.

18.

The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A.

Pediatr Transplant. 1999 May;3(2):152-67.

PMID:
10389139
19.

Mycophenolate mofetil in pediatric renal transplantation.

Benfield MR, Symons JM, Bynon S, Eckhoff D, Herrin J, Harmon W, Kohaut E.

Pediatr Transplant. 1999 Feb;3(1):33-7.

PMID:
10359029
20.
21.

Pediatric renal transplantation: indications and special considerations. A position paper from the Pediatric Committee of the American Society of Transplant Physicians.

Davis ID, Bunchman TE, Grimm PC, Benfield MR, Briscoe DM, Harmon WE, Alexander SR, Avner ED.

Pediatr Transplant. 1998 May;2(2):117-29. Review.

PMID:
10082443
22.
23.

Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone.

Waldo FB, Benfield MR, Kohaut EC.

Pediatr Nephrol. 1998 Jun;12(5):397-400.

PMID:
9686959
24.

The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation.

Benfield MR, Vail A, Waldo FB, Bucy RP, Kohaut EC.

Pediatr Transplant. 1997 Aug;1(1):90-7.

PMID:
10084793
25.

Pediatric transplant grand rounds.

Benfield MR, Harmon WE.

Pediatr Transplant. 1997 Aug;1(1):65-72. No abstract available.

PMID:
10084789
26.

Growth hormone is safe in children after renal transplantation.

Benfield MR, Kohaut EC.

J Pediatr. 1997 Jul;131(1 Pt 2):S28-31. Review.

PMID:
9255224
27.

Growth hormone induces interferon gamma production and may play a role in the presentation of alloantigens in vitro.

Benfield MR, Vail A, Bucy RP, Weigent DA.

Neuroimmunomodulation. 1997 Jan-Feb;4(1):19-27.

PMID:
9326741
28.

The effect of recombinant human growth hormone on responses to alloantigens in the pediatric transplant patient.

Benfield MR, Vail A, Waldo FB, Bucy RP, Kohaut EC.

Pediatr Nephrol. 1996 Jun;10(3):280-2.

PMID:
8792390
29.

Recombinant human growth hormone augments responses in the mixed leukocyte culture.

Benfield MR, Vail A, Weigent DA.

Transplant Proc. 1994 Feb;26(1):84. No abstract available.

PMID:
8109034
30.

The effect of changes in dialysate volume on glucose and urea equilibration.

Kohaut EC, Waldo FB, Benfield MR.

Perit Dial Int. 1994;14(3):236-9.

PMID:
7948234
31.

Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone.

Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benfield MR, Kohaut EC.

Pediatr Nephrol. 1993 Oct;7(5):529-32.

PMID:
8251315
32.

Growth hormone in the treatment of growth failure in children after renal transplantation.

Benfield MR, Parker KL, Waldo FB, Overstreet SL, Kohaut EC.

Kidney Int Suppl. 1993 Oct;43:S62-4. Review.

PMID:
8246372
33.

Murine APC activation in the xenogeneic MLC.

Benfield MR, Witson JC, Alter BJ, Bach FH.

Scand J Immunol. 1993 Aug;38(2):130-6.

PMID:
8346412
34.

Treatment of growth failure in children after renal transplantation.

Benfield MR, Parker KL, Waldo FB, Overstreet SL, Kohaut EC.

Transplantation. 1993 Feb;55(2):305-8.

PMID:
8434381
35.

Methylprednisolone treatment of patients with steroid-resistant nephrotic syndrome.

Waldo FB, Benfield MR, Kohaut EC.

Pediatr Nephrol. 1992 Nov;6(6):503-5.

PMID:
1482631
36.

Human anti-murine mixed leukocyte culture: effects of cytokines.

Benfield MR, Witson JC, Alter BJ, Bach FH.

Transplant Proc. 1991 Feb;23(1 Pt 1):219. No abstract available.

PMID:
1824977
37.

A "minimal signal-stepwise activation" analysis of functional maturation of T lymphocytes.

Bach FH, Geller RL, Nelson PJ, Panzer S, Gromo G, Benfield MR, Inverardi L, Podack ER, Witson JC, Houchins JP, et al.

Immunol Rev. 1989 Oct;111:35-57. Review. No abstract available.

PMID:
2534115

Supplemental Content

Loading ...
Support Center